Not buying it, DD. Definitely not buying it.
If there's a buyout...not buying it...maybe.
Depends on who's buying and the terms.
R&D and products stay, but Ashton goes.
Clinically competent. CEO incompetent.
Maybe folks will buy into buyer's stock.
Nothing I say, post, or do should ever be considered financial advice. It is just my personal opinion. I may be holding a long, short or no position. I am NOT or NEVER have been compensated to post on here and my posts are for entertainment purposes only.